CONSULTING AGREEMENTConsulting Agreement • June 22nd, 2018 • Constellation Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
Contract Type FiledJune 22nd, 2018 Company Industry JurisdictionTHIS CONSULTING AGREEMENT (together with Schedule A and Schedule B, the “Agreement”), effective as of July 15, 2017 (the “Effective Date”) is entered into by Constellation Pharmaceuticals, Inc., a Delaware corporation with its principal place of business at 215 First Street, Suite 200, Cambridge, MA 02142 (the “Company”), and Dr. James Audia residing at 3425 N. Bell Ave., Chicago, IL 60618 (the “Consultant”).
CONSULTING AGREEMENTConsulting Agreement • April 27th, 2018 • Constellation Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
Contract Type FiledApril 27th, 2018 Company Industry JurisdictionTHIS CONSULTING AGREEMENT (together with Schedule A and Schedule B, the “Agreement”), effective as of July 15, 2017 (the “Effective Date”) is entered into by Constellation Pharmaceuticals, Inc., a Delaware corporation with its principal place of business at 215 First Street, Suite 200, Cambridge, MA 02142 (the “Company”), and Dr. James Audia residing at 3425 N. Bell Ave., Chicago, IL 60618 (the “Consultant”).